adalat
bayer s.a. - nifedipina - capsulas blandas - nifedipina 10 mg
aptivus
boehringer ingelheim s.a. - tripanavir - capsulas blandas - tripanavir 250 mg
acidos omega 3 sandoz 1.000 mg capsulas blandas efg
sandoz farmaceutica, s.a. - acidos omega 3 esteres etilicos - excipientes: glicerol,capsulas de gelatina blanda - agentes modificadores de los lÍpidos, monofÁrmacos - otros agentes modificadores de los lípidos - triglicéridos omega-3, incluidos otros ésteres y ácidos
kreon 5.000 u granulado gastrorresistente
mylan ire healthcare limited - lipasa; amilasa; proteasa - granulado gastrorresistente - 5.000 u/3.600 u/200 u - lipasa 5000 u; amilasa 3600 u; proteasa 200 u - multienzimas (lipasa, proteasa, etc.)
andriol testocaps 40 mg c
msd farmaceutica, c.a. - testosterona - c - 40 mg (a3)
glyvenol 400 mg capsulas
novartis de venezuela, s.a. - tribenosido - c - 400 mg
dinamotonic capsula blanda
mega labs latam s.a. - capsula blanda - por ; acetato de alfa tocoferol 200.000000 mg; ascorbato de calcio dihidrato 302.578000 mg; levadura con selenio 50.000000 mg; citrato de zinc 24.026000 mg; - multivitamínicos con otros minerales, incl. combinaciones
rocaltrol 0.50 mcg capsula
productos roche q.f.s.a. - capsula - por ; calcitriol 0.500000 mcg; - calcitriol
rocaltrol 0.25 mcg capsula
productos roche q.f.s.a. - capsula - por ; calcitriol 0.250000 mcg; - calcitriol
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.